"The Parkinson’s Disease & Movement Disorders Center of Boca Raton provides clinical care and access to ongoing clinical trials for Parkinson’s disease and related disorders. Founded in 1999, the Center is located at 951 NE 13th Street, Building 5-E, Boca Raton, FL 33486."

During the past decade, Parkinson's Disease and Movement Disorders Center of Boca Raton conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 36 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 22 clinical trials were completed. i.e. 78.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parkinson's Disease and Movement Disorders Center of Boca Raton" #1 sponsor was "Ipsen" with 6 trials, followed by "Sunovion" with 6 trials sponsored, "ACADIA Pharmaceuticals Inc." with 4 trials sponsored, "Biogen" with 4 trials sponsored and "Jazz Pharmaceuticals" with 4 trials sponsored. Other sponsors include 63 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parkinson's Disease and Movement Disorders Center of Boca Raton" #1 collaborator was "Acorda Therapeutics" with 2 trials as a collaborator, "Denali Therapeutics Inc." with 2 trials as a collaborator, "Institute for Neurodegenerative Disorders" with 2 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator and "Michael J. Fox Foundation for Parkinson's Research" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Parkinson's Disease and Movement Disorders Center of Boca Raton" are "Parkinson Disease" (23 trials), "Parkinson's Disease" (19 trials), "Alzheimer's Disease" (4 trials), "Cervical Dystonia" (4 trials) and "Multiple System Atrophy" (4 trials). Many other conditions were trialed in "Parkinson's Disease and Movement Disorders Center of Boca Raton" in a lesser frequency.

Most popular intervention types in "Parkinson's Disease and Movement Disorders Center of Boca Raton" are "Drug" (80 trials), "Other" (9 trials), "Biological" (8 trials), "Device" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (44 trials), "APL-130277" (5 trials), "Botulinum toxin type A" (4 trials), "ampreloxetine" (3 trials) and "Accordion Pill™ Carbidopa/Levodopa" (2 trials). Other intervention names were less common.

The vast majority of trials in "Parkinson's Disease and Movement Disorders Center of Boca Raton" are 92 trials for "All" genders.

Currently, there are NaN active trials in "Parkinson's Disease and Movement Disorders Center of Boca Raton". undefined are not yet recruiting, 11 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 57 completed trials in Parkinson's Disease and Movement Disorders Center of Boca Raton, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Parkinson's Disease and Movement Disorders Center of Boca Raton, 5 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 3 trials that are defined as “Not Applicable".